Src family kinase inhibitor PP2 accelerates differentiation in human intestinal epithelial cells

Amira Seltana1, Amel Guezguez, Manon Lepage

  • 1Laboratory of Intestinal Physiopathology, Department of Anatomy and Cell Biology, Faculty of Medicine and Health Sciences, Université de Sherbrooke, Sherbrooke, QC, Canada J1H 5N4.

Insights

Src family kinases (SFKs) regulate intestinal cell differentiation. Inhibiting SFKs accelerates differentiation, up-regulating key markers and transcription factors, suggesting SFKs control this crucial process.

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Gastroenterology

Background:

  • Proto-oncogene Src is a protein tyrosine kinase critical for cell signaling.
  • Src family kinases (SFKs) regulate cell adhesion, growth, migration, and survival.
  • The role of SFKs in human intestinal cell differentiation requires further elucidation.

Purpose of the Study:

  • To investigate the involvement of SFKs in human intestinal cell differentiation.
  • To determine the impact of SFK inhibition on intestinal cell differentiation markers and regulatory factors.

Main Methods:

  • Utilized Caco-2/15 cell model for studying intestinal differentiation.
  • Employed PP2, a selective SFK inhibitor, to assess the effects of SFK inhibition.
  • Quantified differentiation markers, transcription factors (Cdx2, HNF1α), and epigenetic modifications (H3K27me3).

Main Results:

  • Src activity peaked during early Caco-2/15 cell differentiation.
  • PP2 treatment accelerated intestinal cell differentiation.
  • Significant up-regulation of polarization markers (sucrase-isomaltase, lactase-phlorizin hydrolase, E- and Li-cadherins), transcription factors (Cdx2, HNF1α), and decreased H3K27me3 levels were observed.

Conclusions:

  • SFKs play a significant role in controlling human intestinal epithelial cell terminal differentiation.
  • Inhibition of SFKs promotes differentiation by up-regulating key transcription factors and reducing epigenetic repression.

Related Concept Videos

Role Of Notch Signalling In Intestinal Stem Cell Renewal01:12

Role Of Notch Signalling In Intestinal Stem Cell Renewal

Notch signaling was first discovered in Drosophila melanogaster, where it is involved in cell lineage differentiation. Notch signaling regulates the maintenance and differentiation of intestinal stem cells or ISCs by controlling the expression of atonal homolog 1 or Atoh1. Atoh1 directs cells to differentiate into secretory cells.
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Renewal of Intestinal Stem Cells01:23

Renewal of Intestinal Stem Cells

The intestinal epithelial lining rapidly renews every 4 to 5 days. The renewal is facilitated by intestinal stem cells (ISCs) located at the base of the crypt– a gland located at the bottom of each villus. ISCs divide asymmetrically to form new stem cells and progenitor daughter cells. The daughter cells are called transit-amplifying (TA) cells which move upwards along the crypt and either differentiate into absorptive cells– the enterocytes or secretory cells– including the goblet,...